Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06385392 · ClinicalTrials.gov registry record
Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.
A clinical trial of Parkinson Disease, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 31
- Enrollment target
- 2
- Study locations
NCT06385392: Completed study of Parkinson Disease, sponsored by HealthPartners Institute.
NCT06385392 is a study of Parkinson Disease that has completed, run by HealthPartners Institute. The registered enrollment target is 31 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06385392, a study of Parkinson Disease, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed system (haptic module and insole device) for daily in-community use that detects the occurrence of freezing of gait (FOG) in people with Parkinson's disease (PD). and triggers external cueing stimuli to unfreeze the individual. The purpose of the overall Phase II study is to: (1) Develop a production ready system, (2) Develop a companion mobile app for the proposed system and refine previously developed FOG detection algorithms, and (3) Validate the proper operation of the system and demonstrate its efficacy through lab and in-community testing. This study will focus on validating the system and demonstrating efficacy through in-community testing.
Primary Outcome
Change in duration of FOG events. Decreased duration of FOG events indicates higher efficacy of device system.
Conditions Studied
Interventions
- DEVICE Haptic module and insole device
Study Locations (2)
Minnesota
- Struthers Parkinson's Center - Golden Valley
- HealthPartners Neuroscience Center - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-09-11 |
| Est. Completion | 2025-04-28 |
What the finished NCT06385392 record still lists
NCT06385392 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Haptic module and insole device is the first listed.
NCT06385392 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06385392 about?
NCT06385392 is a clinical study titled "Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.". The proposed system (haptic module and insole device) for daily in-community use that detects the occurrence of freezing of gait (FOG) in people with Parkinson's disease (PD). and triggers external cueing stimuli to unfreeze the individual. The purpose of the overall Phase II study is to: (1) Develo...
What is the current status of trial NCT06385392?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2024-09-11. Estimated completion is 2025-04-28.
What conditions does trial NCT06385392 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT06385392?
The interventions under investigation include: Haptic module and insole device (DEVICE).
Who is sponsoring clinical trial NCT06385392?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06385392 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06385392's enrollment target sits among peer trials
31 205th of 297 higher than 90 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI